Rivaroxaban vs Streptococcus Pneumoniae Polysaccharide Conjugated To Tetanus Toxoid

## Rivaroxaban vs Streptococcus Pneumoniae Polysaccharide Conjugated To Tetanus Toxoid: Overview

This comparison examines the pharmacological differences between **Rivaroxaban** and **Streptococcus Pneumoniae Polysaccharide Conjugated To Tetanus Toxoid**.

## Mechanism of Action

**Rivaroxaban**: Direct Factor Xa inhibitor.

## Pharmacokinetics

**Half-life**: Rivaroxaban — 5-9 hours; Streptococcus Pneumoniae Polysaccharide Conjugated To Tetanus Toxoid — N/A.

## Chemical Properties

**Molecular Formula**: Rivaroxaban — C19H18ClN3O5S; Streptococcus Pneumoniae Polysaccharide Conjugated To Tetanus Toxoid — N/A.

**Molecular Weight**: Rivaroxaban — 435.8820 g/mol; Streptococcus Pneumoniae Polysaccharide Conjugated To Tetanus Toxoid — N/A.

**Type**: Rivaroxaban — Small molecule; Streptococcus Pneumoniae Polysaccharide Conjugated To Tetanus Toxoid — Vaccine component.